IAJPR

Indo American Journal of Pharmaceutical Research

ISSN NO.: 2231-6876
NOVEMBER 2023
1

REVIEW ON “EXTRACTION OF IN VITRO ANTHELMINTNIC ACTIVITY USING MENTHA SPEAR MINT”

Bongirwar Nidhi*1, Dasari Srinu2, Kachu Bharath3, Mohammad Gousuddin4, Sanidul Islam5, Dr. Chandrasekhara Rao Baru6, Dr. Tripuramallu Rajithasree7

Chilkur Balaji College of Pharmacy, Aziz Nagar, RR District.

Mentha cardifolia [family: Lamiaceae],as known as Mint or spearmint is daily usage herb used to flavor food and herbal tea. Traditional medicinal plant in southeast Asia and Indo- China .It has been shown to possess antioxidant and antihypertensive effects .It is also used in the cure or headache ,toothache ,arthritis and dysmenorrhea ,Mentha species are widely used in savory dishes, food ,beverages and confectionary products .Different parts of the plant including its leaves, flowers,stem,bark and seeds have been also used widely in traditional folk medicine as antimicrobial carminative stimulant,antispasmotic and for the treatment of various diseases such as headache and digestive disorders.The present work aims at evaluation of anthelmintic property of Mentha cardifolia leaves extract against Indian adult earthworm pheritmaposthuma, Albendazole was used as the standard drugs. Petroleum ether,chloroform, ethanol and extracts at concentration of 35mg/ml.Each were evaluated for anthelmintic activity.The time taken for paralysis and death of each worm were determined among chloroform ethanol,aqueous and petroleum ether extracts, chloroform extract by including paralysis within 2 min and death within 5 min .This shows the better anthelmintic activity when compared to standard drug. 


 


2

THE REVOLUTIONARY IMPACT OF ARTIFICIAL INTELLIGENCE ON MEDICATION ADHERENCE

Dr. Tripuramallu RajithaSree1*, Manik .vaishnaviYadav2, Vitrouthi Akshitha Varma3, Bongirwar Nidhi4, Dr. Chandrasekhara Rao Baru5

Chilkur Balaji College of Pharmacy, Aziz Nagar, RR District.

Artificial intelligence (AI) has the potential to significantly improve medication adherence, leading to better health outcomes and lower healthcare costs. AI can create personalized medication plans, send notifications and reminders, identify obstacles to adherence, and track prescription usage. AI-powered solutions can help patients take their medications more consistently, reducing the risk of missed doses, taking medication when it shouldn't be taken, or stopping treatment early. AI can also provide personalized care, early intervention, patient empowerment, data-driven decision-making, reduced transmission rates, and accessible healthcare. AI smartphone applications have been used to monitor and promote medication adherence, while reminder programs and intelligent patient assistance have been implemented to encourage adherence. Despite the potential benefits, there are challenges and ethical considerations to consider, such as algorithm bias, data privacy, and the need for ethical AI development and implementation. Ensuring that AI tools are available and affordable to all patients is crucial to prevent healthcare disparities and ensure the availability of AI tools to all patients. 


 


3

NAVIGATING THE NEXUS:A COMPREHENSIVE REVIEW OF BIOPHARMACEUTICS AND PHARMACOKINETICS IN UNRAVELLING THE COMPLEXITIES OF DRUG ABSORPTION.

Aravind Ghosh. S1*, Seetharam Gude1*, Konduri Bala Siva Sai Narendra1, Muppalla Triveni1, P. Srinivasa Babu1

Dept. of Pharmaceutics, Vignan Pharmacy College, Vadlamudi, Guntur, 522213.

In the labyrinthine realm of drug development, the symbiotic disciplines of biopharmaceutics and pharmacokinetics emerge as indispensable navigators, steering the course from formulation to therapeutic efficacy. This comprehensive review intricately weaves through the multifaceted landscape of drug absorption, unravelling the synergistic dance between these pivotal realms. From decoding drug formulation intricacies to exploring the dynamic interplay between drugs and physiological systems, this article immerses the reader in the cellular ballet of absorption mechanisms. With a spotlight on influential factors and pioneering delivery systems, the narrative extends to the integration of in vitro and in vivo models, ultimately culminating in a forward-looking examination of challenges and future trajectories. "Navigating the Nexus" serves as a guiding beacon, inviting researchers and practitioners to embark on a captivating journey through the complexities of biopharmaceutics and pharmacokinetics, shedding light on the nexus where drug development meets scientific innovation.